About
Crevast F 10 Tablet combines Rosuvastatin and Fenofibrate, offering a dual approach to managing complex dyslipidemia. Rosuvastatin, a potent HMG-CoA reductase inhibitor, effectively lowers elevated LDL cholesterol and triglycerides while raising HDL cholesterol. Fenofibrate, a fibric acid derivative, primarily targets high triglyceride levels and also helps to increase HDL cholesterol and reduce small, dense LDL particles, which are particularly atherogenic. This combination is especially beneficial for patients with mixed dyslipidemia, particularly those with significantly elevated triglycerides and low HDL cholesterol, who may not achieve adequate lipid control with statin monotherapy alone. By addressing multiple lipid abnormalities comprehensively, this medication aims to significantly reduce the overall risk of cardiovascular disease and its associated complications.
Uses
- Treatment of mixed dyslipidemia.
- Management of severe hypertriglyceridemia.
- Patients with low HDL cholesterol and high triglycerides.
- When statin monotherapy is insufficient for lipid control.
Directions For Use
Take one tablet orally once daily, preferably with a meal to enhance absorption of fenofibrate, or as directed by your physician. Do not crush or chew.
Benefits
- Potently lowers both LDL cholesterol and triglycerides.
- Significantly increases beneficial HDL cholesterol.
- Addresses complex lipid abnormalities effectively.
- Reduces the risk of pancreatitis due to high triglycerides.
- Offers comprehensive lipid profile improvement.
- Decreases overall cardiovascular risk.
Side Effects
- Muscle pain or weakness
- Headache
- Nausea
- Abdominal pain
- Constipation
- Diarrhea
- Dizziness
- Fatigue
- Gallstones
- Liver enzyme elevations
- Increased blood sugar levels
- Pancreatitis (rare)
Safety Measures
- Alcohol - Avoid excessive alcohol consumption as it can increase the risk of liver problems and pancreatitis, especially with fenofibrate.
- Pregnancy - Contraindicated during pregnancy due to potential fetal harm from rosuvastatin. Fenofibrate's safety in pregnancy is not established.
- Breastfeeding - Not recommended during breastfeeding as components may pass into breast milk and pose risks to the infant.
- Liver - Use with extreme caution in patients with liver impairment; contraindicated in active liver disease due to both components.
- Kidney - Dose adjustments are necessary in patients with renal impairment; contraindicated in severe renal dysfunction.
- Lung - Generally safe, but report any new or worsening respiratory symptoms to a doctor.
Disclaimer
MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.
Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.
Our goal is to complement, not replace, the essential doctor-patient relationship.
| Shipping Cost |
|
| Shop Location | Assam, India |
No comments found for this product. Be the first to comment!